Comparison of the incidence of facial nerve dysfunction in patients submitted to surgery for parotid gland tumors with or without facial nerve monitoring with continuous electromyographic register during the surgery

ISRCTN ISRCTN13966417
DOI https://doi.org/10.1186/ISRCTN13966417
Secondary identifying numbers CAAE: 27574914.4.2094.5404
Submission date
04/02/2018
Registration date
01/03/2018
Last edited
12/12/2019
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Surgery
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Background and study aims
The parotid gland is situated in the mouth and makes saliva. Lumps can occur in this gland due to abnormal growth, and are called parotid gland tumours. They can be removed by surgery called superficial parotidectomy. Temporary facial nerve weakness (dysfunction) is the most common complication following this surgery, caused by damage to an important nerve that passes through the parotid gland, called the facial nerve.
A series of techniques called continuous intraoperative electromyography can be used to monitor the electrical activity of the facial nerve in an attempt to reduce the incidence of this complication.
The objective of this study is to prospectively evaluate adult patients with benign parotid tumors that will be treated with superficial parotidectomy with or without facial nerve monitoring, and compare the rates and degree of immediate facial nerve dysfunction between these groups and evaluate specific patient outcome results related to these facial disabilities.
This study aims to see if facial nerve monitoring reduces the rate and degree of facial nerve dysfunction following facial surgery to remove parotid tumours.

Who can participate?
Adults aged 18 to 85 years with benign parotid tumours

What does the study involve?
Participants are randomly allocated to the intervention group or control group.
Those in the intervention group undergo superficial parotidectomy with continuous facial nerve monitoring using intraoperative electromyography. Those in the control group have the surgery with standard visual facial nerve monitoring.
Participants have their facial movements filmed prior to surgery and at 7, 30, 90 and 180 days after the procedure.

What are the possible benefits and risks of participating?
Participants may benefit from the reduced risk of face paralysis during surgery and also help others benefit from this in the future if monitoring is shown to be successful.
There are no additional risks for participants, other than those already related to this type of surgery, such as pain and discomfort in the operated area, temporary or permanent facial paralysis and facial hematoma (bleeding under the skin of the face).

Where is the study run from?
1. Hospital das Clínicas da Universidade Estadual de Campinas (Brazil)
2. Hospital São José Joinville (Brazil)

When is the study starting and how long is it expected to run for?
April 2015 to June 2018

Who is funding the study?
Investigator initiated and funded

Who is the main contact?
Dr Agnaldo Jose Graciano (Scientific)
agnaldograciano@gmail.com

Contact information

Dr Agnaldo Graciano
Scientific

Faculty of Medical Sciences
State University of Campinas
Rua Tessália Vieira de Camargo 126
Cidade Universitária
Campinas
13083-887
Brazil

ORCiD logoORCID ID 0000-0003-4643-929X
Phone +55 47 3422 8262
Email agnaldograciano@gmail.com

Study information

Study designTwo center prospective randomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeOther
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet.
Scientific titleFacial Nerve Monitoring during superficial parotidectomy for benign tumors of the parotid gland: a prospective randomized trial
Study objectivesFacial nerve monitoring may reduce the incidence of facial nerve dysfunction and/or it's degree following superficial parotidectomy
Ethics approval(s)Ethical Committee of the Faculty of Medical Sciences State University of Campinas, 09/04/2015, ref: 1008.206
Health condition(s) or problem(s) studiedFacial nerve dysfunction following superficial parotidectomy
InterventionParticipants with benign tumours of the parotid gland undergoing superficial parotidectomy are randomly assigned to the intervention (facial nerve monitoring) or control group on the day of surgery, using a randomized list created by random allocation software.
The intervention group undergo surgery with facial nerve monitoring using continuous intraoperative electromyography, which registers any stimulus that could indicate an irritation of the facial nerve.
The control group undergo standard surgery with continuous visual monitoring of the facial nerve, but no additional information from the electromyographic register.
Post operative facial nerve movement will be recorded using a HD camera and graded by experienced physicians at 30, 90 and 180 days after the surgery.
Intervention typeProcedure/Surgery
Primary outcome measureIncidence of facial nerve dysfunction measured by experienced physicians up to 30 days (immediate) and 180 days (late) following superficial parotidectomy
Secondary outcome measuresDegree of facial nerve dysfunction evaluated by experienced physicians at 30, 90 and 180 days following surgery
Overall study start date15/01/2015
Completion date15/09/2018

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participants150
Total final enrolment124
Key inclusion criteria1. Adult
2. Aged 18 to 85 years
3. Benign parotid tumor(s)
4. Normal neuromuscular facial function prior to surgery
Key exclusion criteria1. Malignant parotid tumor(s)
Date of first enrolment15/04/2015
Date of final enrolment15/06/2018

Locations

Countries of recruitment

  • Brazil

Study participating centres

Hospital das Clínicas da Universidade Estadual de Campinas
Campinas
13083-888
Brazil
Hospital São José Joinville
Joinville
89202-000
Brazil

Sponsor information

Faculty of Medical Sciences - UNICAMP
University/education

Rua Tessália Vieira de Camargo
126 - Cidade Universitária Zeferino Vaz.
Campinas
13083-887
Brazil

ROR logo "ROR" https://ror.org/04wffgt70

Funders

Funder type

Other

Investigator initiated and funded

No information available

Results and Publications

Intention to publish date15/11/2018
Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryAvailable on request
Publication and dissemination planWe plan to publish the results of this trial in a peer reviewed medical periodical.
IPD sharing planThe datasets generated during and/or analysed during the current study are/will be available upon request from Dr Agnaldo Graciano at agnaldograciano@gmail.com. Individual participant data that underlie the results reported in this article, including text, tables, figures, appendices and study protocol will be available for researchers that provide a proposal for individual participant data meta-analysis. Beginning 3 months ending 3 years after publication.

Additional and raw data can be accessed at: http://repositorio.unicamp.br/handle/REPOSIP/332793 (added 12/12/2019)

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/11/2018 Yes No

Editorial Notes

12/12/2019: The following changes were made to the trial record:
1. Publication reference added.
2. The total final enrolment was added.
3. A link to access the raw data was added to the publication and dissemination plan.